Search research articles
Contact Us
Filters
Showing results (321-330 of 505) with videos related to
Page
of 51
Sort By:
European Journal of Clinical Pharmacology
|
August 13, 2015
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
Dave Singh, Leonard Siew, Jared Christensen, et al.
Clinical Pharmacology and Therapeutics
|
December 24, 2025
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose Trial
Dave Singh, Chaim M Brickman, Peter Lloyd, et al.
The European Respiratory Journal
|
March 24, 2012
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study
Paul W Jones, Dave Singh, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 4, 2020
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David M G Halpin, Gerard J Criner, Alberto Papi, et al.
British Journal of Clinical Pharmacology
|
July 22, 2021
A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma
Dave Singh, Rainard Fuhr, Nicholas P Bird, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 12, 2019
DuoResp<sup>®</sup> Spiromax<sup>®</sup> adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT)
Job van der Palen, Isa Cerveri, Nicolas Roche, et al.
Therapeutic Advances in Respiratory Disease
|
March 12, 2025
Predicting response to benralizumab in patients with COPD: a plain language summary of publication of the GALATHEA and TERRANOVA studies
Gerard J Criner, Dave Singh, Alberto Papi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 14, 2008
Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504)
Lauren M Kent, Lucy J C Smyth, Jonathan Plumb, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
December 3, 2020
Current developments and future directions in COPD
Alexander G Mathioudakis, Lowie E G W Vanfleteren, Lies Lahousse, et al.
ERJ Open Research
|
September 10, 2019
Comparative effectiveness of triple therapy <i>versus</i> dual bronchodilation in COPD
Jaco Voorham, Massimo Corradi, Alberto Papi, et al.
Page
of 51
Search research articles
Search
Showing results (321-330 of 505) with videos related to
Sort By:
Page
of 51
European Journal of Clinical Pharmacology
|
August 13, 2015
Oral and inhaled p38 MAPK inhibitors: effects on inhaled LPS challenge in healthy subjects
Dave Singh, Leonard Siew, Jared Christensen, et al.
Clinical Pharmacology and Therapeutics
|
December 24, 2025
Verekitug, a Novel Antibody Antagonist to the TSLP Receptor in Adults with Asthma: A 32-Week Randomized Phase 1b Multiple Ascending-Dose Trial
Dave Singh, Chaim M Brickman, Peter Lloyd, et al.
The European Respiratory Journal
|
March 24, 2012
Efficacy and safety of twice-daily aclidinium bromide in COPD patients: the ATTAIN study
Paul W Jones, Dave Singh, Eric D Bateman, et al.
American Journal of Respiratory and Critical Care Medicine
|
November 4, 2020
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease
David M G Halpin, Gerard J Criner, Alberto Papi, et al.
British Journal of Clinical Pharmacology
|
July 22, 2021
A Phase 1 study of the long-acting anti-IL-5 monoclonal antibody GSK3511294 in patients with asthma
Dave Singh, Rainard Fuhr, Nicholas P Bird, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|
July 12, 2019
DuoResp<sup>®</sup> Spiromax<sup>®</sup> adherence, satisfaction and ease of use: findings from a multi-country observational study in patients with asthma and COPD in Europe (SPRINT)
Job van der Palen, Isa Cerveri, Nicolas Roche, et al.
Therapeutic Advances in Respiratory Disease
|
March 12, 2025
Predicting response to benralizumab in patients with COPD: a plain language summary of publication of the GALATHEA and TERRANOVA studies
Gerard J Criner, Dave Singh, Alberto Papi, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
November 14, 2008
Inhibition of lipopolysaccharide-stimulated chronic obstructive pulmonary disease macrophage inflammatory gene expression by dexamethasone and the p38 mitogen-activated protein kinase inhibitor N-cyano-N'-(2-{[8-(2,6-difluorophenyl)-4-(4-fluoro-2-methylphenyl)-7-oxo-7,8-dihydropyrido[2,3-d] pyrimidin-2-yl]amino}ethyl)guanidine (SB706504)
Lauren M Kent, Lucy J C Smyth, Jonathan Plumb, et al.
European Respiratory Review : an Official Journal of the European Respiratory Society
|
December 3, 2020
Current developments and future directions in COPD
Alexander G Mathioudakis, Lowie E G W Vanfleteren, Lies Lahousse, et al.
ERJ Open Research
|
September 10, 2019
Comparative effectiveness of triple therapy <i>versus</i> dual bronchodilation in COPD
Jaco Voorham, Massimo Corradi, Alberto Papi, et al.
Page
of 51